Molinalogo

Measure

2023 Rate

2023 Goal

2024 Rate

2024 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

65.12%

64.90%

68.04%

66.15%

Annual Dental Visits (ADV) Total

NB

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

46.35%

46.74%

46.71%

48.16%

Appropriate Testing for Pharyngitis (CWP)

75.10%

77.56%

83.89%

85.11%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

95.88%

93.08%

94.52%

91.27%

Asthma Medication Ratio (AMR) Total

78.47%

69.41%

74.60%

70.56%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

73.01%

66.19%

70.21%

67.03%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

72.26%

68.61%

71.05%

71.78%

Breast Cancer Screening (BCS)

48.71%

55.25%

Breast Cancer Screening (BCS-E)

48.57%

54.94%

48.83%

56.66%

Cervical Cancer Screening (CCS)

59.12%

59.85%

53.77%

60.10%

Childhood Immunization Status (CIS) Combination #10

32.60%

35.04%

29.44%

31.32%

Chlamydia Screening in Women (CHL) Total

50.48%

61.07%

51.01%

61.46%

Controlling High Blood Pressure (CBP)

61.31%

65.45%

60.83%

67.40%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

78.84%

80.86%

81.00%

83.51%

Eye Exam for Patients With Diabetes (EED)

50.61%

56.20%

46.96%

57.09%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

33.01%

27.73%

27.92%

27.62%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

51.41%

46.35%

52.12%

44.33%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

39.34%

41.03%

39.75%

42.86%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

37.26%

37.31%

43.32%

37.64%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

55.69%

57.90%

52.41%

56.86%

Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase

52.41%

56.83%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

53.77%

55.72%

53.77%

59.64%

Immunizations for Adolescents (IMA) Combination #2

30.66%

38.93%

32.60%

38.69%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

16.07%

16.94%

16.05%

16.78%

Kidney Health Evaluation for Patients with Diabetes (KED)

41.49%

38.80%

41.95%

42.10%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

28.52%

39.01%

28.70%

41.92%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total

28.70%

41.41%

Pharmacotherapy for Opioid Use Disorder (POD) Total

13.95%

31.93%

12.44%

29.01%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

77.22%

75.79%

75.38%

74.78%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

87.21%

86.96%

84.15%

86.54%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

83.14%

≤ 92.72%

89.81%

≤ 91.24%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

90.27%

86.86%

88.56%

86.89%

Prenatal and Postpartum Care (PPC) Postpartum Care

82.00%

80.78%

84.67%

82.48%

Prenatal Immunization Status (PRS) Combination Rate

28.47%

25.81%

Prenatal Immunization Status (PRS-E) Combination Rate

28.47%

25.81%

26.79%

24.92%

Risk of Continued Opioid Use (COU) 31-Day Total

1.97%

≤ 2.45%

2.08%

≤ 2.79%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

82.24%

81.64%

82.50%

83.00%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

71.02%

73.63%

71.52%

74.07%

Statin Therapy for Patients with Diabetes (SPD)

Received Statin Therapy

63.98%

67.07%

62.49%

67.01%

Statin Therapy for Patients with Diabetes (SPD)

Statin Adherence 80%

68.31%

70.37%

69.39%

70.91%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

59.03%

63.89%

63.18%

64.10%

Use of Imaging Studies for Low Back Pain (LBP)

73.15%

75.44%

70.47%

72.74%

Use of Opioids at High Dosage (HDO)

4.46%

≤ 2.19%

4.39%

≤ 2.14%

Use of Opioids from Multiple Providers (UOP)

Multiple Prescribers and Multiple Pharmacies

2.24%

≤ 0.87%

2.22%

≤ 1.22%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

76.64%

83.21%

73.24%

86.20%